Insider · CIK 0001906486

Daly Jason B.

Reports to the SEC for 1 company · BRIDGEWATER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001906486

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-12	AMRXAmneal Pharmaceuticals, Inc.S Sale	EVP, Chief Legal Officer	SSale	−210K sh	$17.40	−$3.65M	35,171
2026-08-11	AMRXAmneal Pharmaceuticals, Inc.S Sale	EVP, Chief Legal Officer	SSale	−6,613 sh	$17.70	−$117K	245,171
2026-03-04	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+35.9K sh	—	—	267,364
2026-03-04	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−15.6K sh	$13.30	−$207K	251,784
2026-03-04	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−35.9K sh	—	—	71,760
2026-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+22.6K sh	—	—	33,251
2026-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−10.1K sh	$13.31	−$135K	23,104
2026-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+38.2K sh	—	—	61,330
2026-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−16.6K sh	$13.31	−$221K	44,732
2026-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+24.3K sh	—	—	68,990
2026-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−10.5K sh	$13.31	−$140K	58,457
2026-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+306K sh	—	—	364,267
2026-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−133K sh	$13.31	−$1.77M	231,484
2026-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−22.6K sh	—	—	0
2026-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−38.2K sh	—	—	38,227
2026-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−24.3K sh	—	—	72,774
2026-03-03	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−306K sh	—	—	0
2026-03-02	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	EVP, Chief Legal Officer	AAward	+65.4K sh	—	—	65,359
2026-03-02	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsA Award	EVP, Chief Legal Officer	AAward	+65.4K sh	—	—	65,359
2025-08-12	AMRXAmneal Pharmaceuticals, Inc.S Sale	EVP, Chief Legal Officer	SSale	−22K sh	$9.05	−$199K	10,606
2025-03-06	AMRXAmneal Pharmaceuticals, Inc.S Sale	EVP, Chief Legal Officer	SSale	−46.9K sh	$8.73	−$410K	32,606
2025-03-05	AMRXAmneal Pharmaceuticals, Inc.S Sale	EVP, Chief Legal Officer	SSale	−43.1K sh	$8.88	−$382K	79,542
2025-03-04	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+35.9K sh	—	—	138,185
2025-03-04	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−15.6K sh	$8.84	−$138K	122,606
2025-03-04	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−35.9K sh	—	—	107,640
2025-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+22.6K sh	—	—	22,645
2025-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−6,943 sh	$8.76	−$60.8K	15,702
2025-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+38.2K sh	—	—	53,928
2025-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−10.9K sh	$8.76	−$95.2K	43,064
2025-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+90.6K sh	—	—	133,644
2025-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−31.3K sh	$8.76	−$275K	102,306
2025-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−22.6K sh	—	—	22,645
2025-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−38.2K sh	—	—	76,453
2025-03-03	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−90.6K sh	—	—	0
2025-03-03	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsA Award	EVP, Chief Legal Officer	AAward	+194K sh	—	—	194,064
2025-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	EVP, Chief Legal Officer	AAward	+97K sh	—	—	97,032
2024-11-21	AMRXAmneal Pharmaceuticals, Inc.S Sale	EVP, Chief Legal Officer	SSale	−13.7K sh	$8.40	−$115K	0
2024-11-15	AMRXAmneal Pharmaceuticals, Inc.S Sale	EVP, Chief Legal Officer	SSale	−43.7K sh	$8.61	−$376K	13,665
2024-03-04	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	EVP, Chief Legal Officer	AAward	+144K sh	—	—	143,519
2024-03-04	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsA Award	EVP, Chief Legal Officer	AAward	+287K sh	—	—	287,038
2024-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+22.6K sh	—	—	37,126
2024-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−7,166 sh	$5.47	−$39.2K	29,960
2024-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+38.2K sh	—	—	68,186
2024-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−10.9K sh	$5.47	−$59.4K	57,322
2024-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−22.6K sh	—	—	45,290
2024-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−38.2K sh	—	—	114,679
2023-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+22.6K sh	—	—	22,645
2023-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−8,164 sh	$1.92	−$15.7K	14,481
2023-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−22.6K sh	—	—	67,935
2023-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	EVP, Chief Legal Officer	AAward	+153K sh	—	—	152,905

Recent filings

Accepted (ET)
Aug 134
Daly Jason B.0001628280-26-056754
SEC(opens sec.gov)
Mar 54
Daly Jason B.0001628280-26-015241
SEC(opens sec.gov)
Mar 34
Daly Jason B.0001628280-26-013882
SEC(opens sec.gov)
Aug 134
Daly Jason B.0001723128-25-000049
SEC(opens sec.gov)

Companies

Amneal Pharmaceuticals, Inc.EVP, Chief Legal OfficerAMRX

Address

C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD

BRIDGEWATER, NJ, 08807